Article: UBC Receives First Milestone Payment from Forbes Under Revised License Agreement; $250,000 Milestone Payment One of the Largest Received to Date.

VANCOUVER, British Columbia--(BUSINESS WIRE)--Nov. 18, 1999--

Forbes Medi-Tech(TSE:FMI.) UBC Forbes Medi-Tech (FMI: TSE) and the University of British Columbia (UBC) today announced that Forbes has paid UBC $250,000 as a first royalty payment under the Forbes/UBC License Agreement. This represents a portion of a milestone payment Forbes recently received under its Master License Agreement with Novartis Consumer Health to use or sub-license Phytrol(TM) - Forbes' sterol-based cholesterol-lowering functional food ingredient.

"This payment is one of the largest single milestone payments we have received to date," said Angus Livingstone, Managing Director of ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!